Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD
Status:
Completed
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Recruitment of patients with COPD. Assessment of clinical status, determination of vitamin D
and cathelicidin levels. In the group with vitamin D deficiency, patients receive
cholecalciferol (vitamin D) daily for 3 months. After 3 months, the clinical status was
assessed again, the level of vitamin D and cathelicidin was determined. When vitamin D levels
normalize, cholecalciferol replacement therapy is discontinued for 3 months. After that, a
control inspection and laboratory tests are performed.